Welcome to DigitexMedwire Research

Friends, we are so happy and excited to introduce our first ever blogging platform dedicated to Global healthcare industry. With global economy growing at 4% and world healthcare industry growing at an impressive rate of 17% annually, our team couldn’t manage a better time than now to share our knowledge tank with you people. Dear partners, friends, customers, well wishers and society in general, you can expect us bring you the best articles, write ups, news columns, reports and events update on cutting edge technologies and latest lifestyle trends in the Indian and International markets. This blog is an interim platform for leaders in making and leaders in practice who pursue ‘knowledge’ as their platform to success. This blog site is a product of DMSMedwire Research ‘knowledge sharing program’ and is a signature to our long term business expansion plans and corporate identity.

We wish all our fellow readers, best of luck. Happy Reading!

Monday, October 6, 2008

Global Cardiovascular Innovation Center Awards $496,000 to Arteriocyte


Arteriocyte, a clinical stage biotechnology company announced today that the company has been awarded $496,000 through the Global Cardiovascular Innovation Center (GCIC), to continue clinical research on its lead stem cell therapy (ACY001) for use in chronic coronary ischemia. This funding is in addition to the first year GCIC support received in 2007, to accelerate the company's cardiac stem cell therapy development. Under the GCIC project, Arteriocyte participates as one of a number of companies working as research partners with the Cleveland Clinic.

Source: marketwatch.com Contributed by: DMSMedwire Research JSG Team
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)